Bipolar II Disorder and Cyclothymic Disorder

Risk factors

• First-degree relative with bipolar disorder (heritability ~70-80%)
• Early onset of depressive symptoms (<25 yo)
• Postpartum mood episode
• Antidepressant-induced hypomania or rapid cycling
• Comorbid substance use, ADHD, anxiety disorders

Pathophysiology

Heritable disturbance of mood regulation involving monoaminergic systems, circadian dysregulation, calcium-channel signaling (CACNA1C), and reduced prefrontal inhibition of limbic structures. Sleep deprivation and antidepressants can precipitate hypomania.

Clinical presentation

Differential diagnosis

• Bipolar I disorder — Requires ≥1 full manic episode (≥7 days, marked impairment, psychosis, or hospitalization) — by definition absent in BPII
• Major depressive disorder — No history of hypomania; carefully screen with MDQ or collateral — antidepressant monotherapy in undiagnosed BPII risks induction of hypomania
• Borderline personality disorder — Mood lability over hours, identity disturbance, fear of abandonment, chronic emptiness — not discrete ≥4-day episodes
• ADHD — Chronic, not episodic; distractibility and impulsivity without elevated mood or decreased need for sleep
• Substance-induced mood disorder — Stimulants, cocaine, glucocorticoids — temporal link to use; resolves with sustained abstinence
• Hyperthyroidism — Tachycardia, weight loss, tremor, suppressed TSH — always check TSH
• Cyclothymic disorder — Chronic subthreshold oscillation never meeting full hypomanic or MDD criteria

Diagnostic workup

Diagnostic algorithm

flowchart TD
  A[Mood symptoms] --> B{Ever a manic episode<br/>≥7 d / hospitalization /<br/>psychosis?}
  B -->|Yes| C[Bipolar I disorder]
  B -->|No| D{Discrete hypomanic<br/>episode ≥4 d?}
  D -->|Yes| E{Ever had a full<br/>major depressive episode?}
  E -->|Yes| F[Bipolar II Disorder]
  E -->|No| G[Other specified<br/>bipolar disorder]
  D -->|No| H{Chronic ≥2 yr<br/>subthreshold up/down?}
  H -->|Yes| I[Cyclothymic Disorder]
  H -->|No| J[Unipolar MDD<br/>or other dx]
  F --> K[Mood stabilizer<br/>± atypical antipsychotic]
  I --> K

Treatment

Complications

• Conversion to bipolar I (~5-15% over time)
• Suicide — bipolar II carries the highest completed suicide rate of any mood disorder
• Substance use disorders (lifetime ~40%)
• Occupational, financial, and relational damage during hypomania
• Lithium: renal, thyroid, parathyroid effects with long-term use
• Valproate: hepatotoxicity, pancreatitis, teratogenicity (neural tube defects)
• Lamotrigine: Stevens-Johnson syndrome (slow titration mandatory)

PANCE pearls

• Hypomania must be observable by others — patient self-report alone is insufficient; obtain collateral.
• An antidepressant-induced hypomanic episode lasting beyond pharmacologic effect counts toward bipolar diagnosis.
• Lamotrigine requires 6-week titration to reduce SJS risk — never load.
• Lithium reduces suicide risk independent of mood effect — strongly consider in any bipolar patient with prior attempts.
• Cyclothymia converts to bipolar I or II in 15-50% of patients over decades.
• Always check beta-hCG and counsel on contraception before valproate (NTD risk) or carbamazepine.

References

• DSM-5-TR — American Psychiatric Association. DSM-5-TR. 2022.
• CANMAT 2018 — Yatham LN et al. CANMAT and ISBD 2018 Guidelines for the Management of Patients with Bipolar Disorder. Bipolar Disord 2018;20(2):97-170.
• APA 2002 — American Psychiatric Association Practice Guideline for the Treatment of Patients with Bipolar Disorder, 2nd ed (with 2005 guideline watch).